FDA Warning Letter Explorer
Drugs · Letter issue date: Oct 30, 2026

RonanRx, Inc. dba RonanRx

3 extracted findings

FDA source excerpt, selected passage

The compounded tirzepatide products displayed on your website and posted on the social media platform “X” by @Ronan_Rx, identify “RonanRx” on the pictured label, suggesting RonanRx is the compounder of those drugs when in fact it is not.

Findings and supporting evidence

Model-assisted readings, not an exhaustive interpretation. Compare with the extracted source findings below.

Findings extracted from the letter

Selected FDA passages, not the complete letter.

01
The compounded tirzepatide products displayed on your website and posted on the social media platform “X” by @Ronan_Rx, identify “RonanRx” on the pictured label, suggesting RonanRx is the compounder of those drugs when in fact it is not.
02
Compounded drug products are not FDA-approved. Your claims represent that the compounded drug products you offer have been FDA-approved or otherwise evaluated for safety and effectiveness when they have not.
03
Describing the finished product as “American made” and “farm-to-table drugs” creates a misleading impression regarding the product’s true origin because, based on FDA’s records, the active pharmaceutical ingredient in the product was not made in the U.S.

Keep exploring

For regulated teams

Put this kind of reading to
work on your own records.

Botable builds and runs a custom AI layer around the software you already use, so your team can do the job you hired them for.

FDA Warning Letter Alerts

Share this view

Send the same filters, search and view to a colleague.

You choose what to post or send. Sharing a link does not change access to this site.